MedTrace Logo

Effect of Smart Watch Monitoring on Stress Levels Among Nursing Students During Older Adult Clinical Training

NCT07757256 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2026-08-11

No results posted yet for this study

Summary

This randomized controlled trial aims to evaluate the effectiveness of smart watch monitoring in reducing stress levels among nursing students during older adult clinical training. Nursing students often experience psychological stress during geriatric clinical practice due to complex patient care and clinical responsibilities. Participants will be randomly assigned to either a smart watch monitoring group or a control group receiving usual clinical training. Stress levels will be assessed using validated instruments, while physiological indicators, including heart rate variability (HRV), will be monitored in the intervention group. The findings will determine whether smart watch monitoring can support stress management and improve students' well-being during clinical training.

Conditions

  • Stress at Clinical Areas

Interventions

DEVICE

smart watch use

Students will wear smartwatches during all clinical training shifts Data (heart rate, steps) will be recorded automatically Students will: Monitor stress indicators Become aware of physiological stress responses Weekly: Students send screenshots from Google Fit to researchers whatsapp or emails Researcher records data in Excel sheet 2- Control Group: Students will undergo routine clinical training No smart watch or monitoring provided Phase 5: Post-test Assessment At the end of the intervention period: Both groups will: Complete Tool II (PSS) Complete Tool IV (Brief COPE) Phase 6: Data Analysis Compare: Pre vs Post within each group Intervention vs Control Analyze: Stress levels (PSS) Physiological stress (HR) Coping strategies (COPE)

Sponsors & Collaborators

  • doaa mansour ali

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Months
Max Age
25 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-28
Primary Completion
2026-10-01
Completion
2026-10-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07757256 on ClinicalTrials.gov